期刊
CLINICAL INFECTIOUS DISEASES
卷 67, 期 5, 页码 795-798出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciy279
关键词
dalbavancin; endocarditis; Gram-positive infection
The clinical outcomes and safety of dalbavancin as primary and sequential treatment of gram-positive bacteremia with infective endocarditis were evaluated retrospectively. The clinical success rate was high (92.6%), but in 24 of 27 patients dalbavancin was used only after clearance of bacteria from the bloodstream.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据